Serdemetan JNJ26854165 CAS: 881202-45-5 is a type of medication used in the treatment of cancer. Its chemical name is N-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]-3-methylquinoxalin-2-carboxamide, and its molecular formula is C16H23N3O3. The formula weight is 305.38 g/mol, and its CAS number is 881202-45-5.
Top ten keywords from Google and Synonyms
Health Benefits of Serdemetan JNJ26854165 Serdemetan JNJ26854165 is a promising medication used in the treatment of cancer. It has the potential to selectively target the Hedgehog signaling pathway and to enhance apoptosis, leading to a reduction in tumor growth and proliferation.
Potential Effects of Serdemetan JNJ26854165 Serdemetan JNJ26854165 has shown promising results in the treatment of various types of cancer, including pancreatic cancer, breast cancer, and colon cancer. Preclinical trials have shown that it may cause significant reduction in tumor growth and proliferation.
Product Mechanism Serdemetan JNJ26854165 is a novel, small molecule inhibitor that selectively targets the Hedgehog signaling pathway, leading to the inhibition of GLI2 transcription factors. This inhibition leads to a reduction in tumor growth through the induction of apoptosis, leading to the elimination of cancer cells.
Safety and Side Effects As with any medication, there are potential side effects and risks associated with using Serdemetan JNJ26854165. While results from preclinical trials have shown positive results of this medication, this medication is still being studied, and therefore more research is required to determine its overall safety and tolerability.
Dosing Information The recommended dose of Serdemetan JNJ26854165 varies depending on the specific condition being treated, the